22.418 articles found

Nematodes as model organisms for the investigation of neurodegenerative diseases, in particular parkinsons disease, uses and methods for the discovery of substances and genes which can used in the treatment of the above disease states and identification of anematode gene

HOENER MARIUS, CASSATA GIUSEPPE, LINK WOLFGANG, BAUMEISTER RALF, TOVAR KARLHEINZ.

· 2003-04-04

Repeated estradiol treatment prevents MPTP-induced dopamine depletion in male mice.

Ramirez AD, Liu X, Menniti FS.

Neuroendocrinology · 2003-04-01

DOI: 10.1159/000070277PMID: 12766322

Biochemical and therapeutic effects of antioxidants in the treatment of Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis.

Di Matteo V, Esposito E.

Curr Drug Targets CNS Neurol Disord · 2003-04-01

DOI: 10.2174/1568007033482959PMID: 12769802

3,4-dihydroxyphenylacetaldehyde: a potential target for neuroprotective therapy in Parkinson's disease.

Burke WJ.

Curr Drug Targets CNS Neurol Disord · 2003-04-01

DOI: 10.2174/1568007033482913PMID: 12769806

[Pathological gambling behavior in a patient with Parkinson's disease treated with levodopa and bromocriptine].

Montastruc JL, Schmitt L, Bagheri H.

Rev Neurol (Paris) · 2003-04-01

PMID: 12773874

Apoptotic mechanisms and antiapoptotic therapy in the MPTP model of Parkinson's disease.

Eberhardt O, Schulz JB.

Toxicol Lett · 2003-04-01

DOI: 10.1016/s0378-4274(02)00428-9PMID: 12628749

Benefit of folic acid supplementation in parkinsonian patients treated with levodopa.

Müller T, Woitalla D, Kuhn W.

J Neurol Neurosurg Psychiatry · 2003-04-01

DOI: 10.1136/jnnp.74.4.549PMID: 12640094

Stem cells for cell therapy in Parkinson's disease.

Lindvall O.

Pharmacol Res · 2003-04-01

DOI: 10.1016/s1043-6618(03)00037-9PMID: 12644384

Prospects for antiapoptotic drug therapy of neurodegenerative diseases.

Waldmeier PC.

Prog Neuropsychopharmacol Biol Psychiatry · 2003-04-01

DOI: 10.1016/s0278-5846(03)00025-3PMID: 12657369

Beta-synuclein inhibits formation of alpha-synuclein protofibrils: a possible therapeutic strategy against Parkinson's disease.

Park JY, Lansbury PT.

Biochemistry · 2003-04-01

DOI: 10.1021/bi020604aPMID: 12667059

Drug therapy of frontotemporal dementia.

Allain H, Bentué-Ferrer D, Tribut O, Mérienne M, Belliard S.

Hum Psychopharmacol · 2003-04-01

DOI: 10.1002/hup.472PMID: 12672175

Efficacy of piribedil as early combination to levodopa in patients with stable Parkinson's disease: a 6-month, randomized, placebo-controlled study.

Ziegler M, Castro-Caldas A, Del Signore S, Rascol O.

Mov Disord · 2003-04-01

DOI: 10.1002/mds.10359PMID: 12671949